| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.002 | 0.9 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.0046 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.0089 | 1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |